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Background
Conclusions
DYRK1A T98G mutants are growing more slowly, entering 
and proceeding through S phase more slowly than control 
T98G cells. This is evidenced by:
• FACS cell cycle data: DYRK1A-KO cells enter S phase 
around the 22 hour mark rather than 16-18 hours.
• EdU staining: DYRK1A-KO cells do not begin to complete 
active DNA synthesis until ~22 hrs
• Cell Cycle markers with WB: Cyclin E, B-myb
accumulates later in the cell cycle in KO lines
DYRK1A may be having an unexpected, but significant 
effect on the cell cycle. Further investigation is needed to 
fully elucidate and understand the roles of DYRK1A in cell 
cycle regulation and arrest.
Future Directions
• Quantification of EdU staining, EdU Cell Cycle FACS
• Probing for additional cell cycle markers (Cyclin A, Cyclin 
B for S/G2 transition)
• Delving deeper into what is happening with Ki67 and 
DYRK1A, potentially IP at various time points in the cell 
cycle for Ki67/DYRK1A interaction
• Additionally, Ki67 staining in T98G control and 
DYRK1A mutant cells at time points throughout 
the cell cycle following synchronization
• Cell line-dependent observation? Use of additional cell 
lines for repeated experiments (Litovchick lab currently 
works with multiple non-cancer and cancer lines with 
DYRK1A-KO)
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Cell Line: T98G cells 
• Human astrocytes, glioblastoma multiforme cells (originally derived from a 61 year-old 
Caucasian male)
• Hyperpentaploid, and typically carry three copies of the DYRK1A gene
Two mutant lines used in these experiments:
• CRISPR DYRK1A-KO lines (labeled as 3.1.A6 and 4.1.A1)
• Grown in Dulbecco’s Modified Eagle Medium (DMEM) + FBS, + penicillin/streptomycin, + 
glutamax. Starvation media in these experiments contained 0% FBS
•Experimental protocol for starvation and release of cells back into cell cycle: plate equal numbers 
of cells  replace media with starvation media for 48 hours  Induces cells to enter 
quiescence/temporary arrest in G1/G0  Release cells back into the cell cycle through 
addition of 15% FBS  Collect samples at 0, 16, and 22 hr timepoints.
•Three methods used to gauge cell cycle progression in T98G cells following starvation 
and release:
•Cell cycle FACS using propidium iodide (Canto flow cytometry)
•Western blot for cell cycle (especially S phase) protein markers
•EdU (Ethynyl deoxyuridine) staining to measure active DNA synthesis across time points
DREAM is a key regulator of cell cycle 
quiescence
• DREAM (DP1, the Rb-related protein p130, E2F4, and the MuvB 
core complex)
• Multi-subunit repressor complex of cell cycle-promoting genes
• Switch from DREAM to BMYB-MuvB (MMB) is highly regulated
DYRK1A (dual specificity tyrosine-(Y)-phosphorylation regulated 
kinase 1A)
• nervous system development, cell growth and division, 
and neuronal differentiation
• Cytogenetic Location: 21q22.13
• Putative tumor suppressor and important regulator of 
many proteins through its kinase activity
• DYRK1A phosphorylates Serine residue 28 on LIN52 of 
the MuvB core, allowing p130 to bind to LIN52. 
Necessary for formation of DREAM complex.
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Figure 1: Using student’s T tests between each group (using JMP statistical software) both DYRK1A-KO 
lines’ 5 day cell count means were significantly different from the control line mean cell count (p=0.001 
for both mutant lines).
Figure 2: T98G and T98G DYRK1A-KO lines 
were starved and then released back into the 
cell cycle. WT T98G proceeds through cell cycle 
checkpoints normally, while DYRK1A-KO lags, 
entering S phase at 22 hours. Quantification 
on right panel. N=3 biological repeats.
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Lab observation: T98G DYRK1A-KO cells appear slightly smaller, and proliferate more 
slowly than control cells.
Unexpected phenotype. DYRK1A is a putative tumor suppressor through phosphorylation of LIN52 
(required for binding of p130 for DREAM assembly).
Research Questions: Is there slower, encumbered DNA synthesis happening in 
DYRK1A-KO cell lines to explain the slower proliferation observed in T98G cells?
What is the underlying mechanism of the delayed proliferation of the DYRK1A-KO 
cells?
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Figure 3: Cell Cycle protein markers 
after starvation and release at 0-22 
hr timepoints. N=3 biological 
repeats. 
Figure 4: EdU staining (30 minute pulse) for T98G control and DYRK1A-KO cells at 0, 16, 22 hr in the 
cell cycle. EdU staining for DNA synthesis in green, and lower panels Hoechst nuclear stain. 
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